Dana Investment Advisors Inc. Boosts Stake in DENTSPLY SIRONA Inc. $XRAY

Dana Investment Advisors Inc. lifted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 45.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 279,954 shares of the medical instruments supplier’s stock after purchasing an additional 87,954 shares during the quarter. Dana Investment Advisors Inc. owned about 0.14% of DENTSPLY SIRONA worth $3,553,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. AQR Capital Management LLC boosted its stake in DENTSPLY SIRONA by 109.8% during the second quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock worth $211,470,000 after buying an additional 6,970,086 shares during the period. Norges Bank acquired a new position in shares of DENTSPLY SIRONA in the 2nd quarter worth approximately $39,700,000. Goldman Sachs Group Inc. boosted its position in shares of DENTSPLY SIRONA by 827.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock worth $36,378,000 after purchasing an additional 2,172,343 shares during the period. Brickwood Asset Management LLP increased its holdings in DENTSPLY SIRONA by 5,515.8% in the 3rd quarter. Brickwood Asset Management LLP now owns 1,524,074 shares of the medical instruments supplier’s stock valued at $19,340,000 after purchasing an additional 1,496,935 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in DENTSPLY SIRONA by 4.1% in the third quarter. Vanguard Group Inc. now owns 22,006,576 shares of the medical instruments supplier’s stock valued at $279,263,000 after purchasing an additional 869,566 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

XRAY has been the subject of several research analyst reports. Wells Fargo & Company lowered their price target on DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a research report on Friday, November 7th. Zacks Research cut DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Mizuho lifted their target price on DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research report on Tuesday, January 20th. Barrington Research reiterated an “outperform” rating and set a $14.00 price target on shares of DENTSPLY SIRONA in a research note on Monday, January 5th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Friday, November 7th. Three investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $14.46.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $13.14 on Wednesday. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. The company has a market cap of $2.62 billion, a price-to-earnings ratio of -2.97, a price-to-earnings-growth ratio of 0.99 and a beta of 1.01. The stock’s 50-day moving average is $12.29 and its two-hundred day moving average is $12.47. DENTSPLY SIRONA Inc. has a 1-year low of $9.85 and a 1-year high of $19.27.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 26th were paid a $0.16 dividend. The ex-dividend date was Friday, December 26th. This represents a $0.64 dividend on an annualized basis and a yield of 4.9%. DENTSPLY SIRONA’s payout ratio is currently -14.48%.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier sold 82,200 shares of the stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a filing with the SEC, which is available through this link. 0.52% of the stock is owned by company insiders.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.